Molina Healthcare, Inc.
HealthcareNYSE:MOH · New York Stock Exchange
+$6.75 today
Vol 1.18M · Avg 1.40M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $5.3B |
| Receivables | $3.4B |
| Other Current | $4.6B |
| Total Current Assets | $13.3B |
| PP&E (Net) | $300.0M |
| Goodwill | $2.1B |
| Tax Assets | $215.0M |
| Other Non-current | $458.0M |
| Total Non-current Assets | $3.1B |
| Total Assets | $16.4B |
Analysis
Selected assets total $16.4B for Latest. The largest visible component is Cash & Equivalents at $5.3B, about 32.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.2B -8.9% | $4.7B -3.8% | $4.8B +21.0% | $4.0B -9.7% | $4.4B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 -100.0% | $4.3B +1.5% | $4.3B +21.7% | $3.5B +9.3% | $3.2B | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $3.5B +7.1% | $3.3B +6.3% | $3.1B +34.8% | $2.3B +5.7% | $2.2B | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $4.7B +857.5% | $487.0M +47.1% | $331.0M +19.5% | $277.0M | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $12.4B -2.6% | $12.8B +1.8% | $12.5B +24.4% | $10.1B +0.2% | $10.1B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $301.0M +4.5% | $288.0M +6.7% | $270.0M +4.2% | $259.0M -34.6% | $396.0M | $1.2B | $1.5B | $687.8M |
| Goodwill | $2.2B +31.4% | $1.7B +34.6% | $1.2B +11.3% | $1.1B +13.5% | $982.0M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $0 -100.0% | $267.0M +28.4% | $208.0M -24.4% | $275.0M +1.9% | $270.0M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $178.0M -14.0% | $207.0M -8.8% | $227.0M +3.2% | $220.0M +107.5% | $106.0M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $446.0M +5.2% | $424.0M +5.0% | $404.0M +11.9% | $361.0M -7.7% | $391.0M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $3.1B +9.2% | $2.9B +21.6% | $2.4B +5.4% | $2.2B +4.0% | $2.1B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $15.6B -0.4% | $15.6B +5.0% | $14.9B +20.9% | $12.3B +0.9% | $12.2B | $13.3B | $11.9B | $10.6B |
| Account Payables | $0 -100.0% | $1.3B +6.3% | $1.3B +40.8% | $889.0M +5.6% | $842.0M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $0 | $0 | $0 | $0 | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 -100.0% | $51.0M -87.8% | $418.0M +16.4% | $359.0M -3.0% | $370.0M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $7.4B | $0 | $0 | $0 | $0 | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $7.4B -6.6% | $7.9B -3.3% | $8.2B +19.2% | $6.9B -2.7% | $7.0B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $3.8B +28.8% | $2.9B +34.1% | $2.2B +0.2% | $2.2B +0.1% | $2.2B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $173.0M +44.2% | $120.0M -3.2% | $124.0M +19.2% | $104.0M -25.7% | $140.0M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $4.1B +27.3% | $3.2B +29.1% | $2.5B +0.6% | $2.5B -1.5% | $2.5B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $11.5B +3.2% | $11.1B +4.3% | $10.7B +14.2% | $9.3B -2.4% | $9.6B | $14.7B | $3.7B | $9.6B |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $3.6B -12.0% | $4.1B +5.2% | $3.9B +39.0% | $2.8B +16.5% | $2.4B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $15.0M +126.3% | -$57.0M +30.5% | -$82.0M +48.8% | -$160.0M -3100.0% | -$5.0M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $4.1B -9.5% | $4.5B +6.7% | $4.2B +42.2% | $3.0B +12.7% | $2.6B | $9.1B | $7.7B | $3.3B |
| Total Debt | $4.0B +26.7% | $3.1B +30.7% | $2.4B -0.3% | $2.4B -0.0% | $2.4B | $724.2M | $410.6M | $399.4M |
| Net Debt | -$298.0M +80.7% | -$1.5B +37.3% | -$2.5B -52.5% | -$1.6B +21.1% | -$2.0B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
DaVita Inc.
NYSE:DVA
$13.48B
Globus Medical, Inc.
NYSE:GMED
$10.89B
Masimo Corporation
NASDAQ:MASI
$9.42B
Henry Schein, Inc.
NASDAQ:HSIC
$9.31B
Halozyme Therapeutics, Inc.
NASDAQ:HALO
$8.26B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.72B
AptarGroup, Inc.
NYSE:ATR
$7.53B
HealthEquity, Inc.
NASDAQ:HQY
$7.38B
Avantor, Inc.
NYSE:AVTR
$6.54B
Grifols, S.A.
NASDAQ:GRFS
$6.50B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does MOH have?
Molina Healthcare, Inc. (MOH) reported $4.25B in cash and equivalents in fiscal 2025.
How much debt does MOH carry?
Molina Healthcare, Inc. (MOH) reported $3.95B of total debt, with net debt of -$298,000,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.